Sylvia Lacourse is an Infectious Disease physician affiliated with University of Washington. OpenAlex indexes 102 publications with 1,810 citations (h-index 20).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
325 9th Ave
Box 359931
Seattle, WA 981042420
Telephone
206-744-5100Registry record last updated 2 Sept 2015.
Industry payments
1 company reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Merck Sharp & Dohme LLCProgram year20251 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Anti-infectives
54.3%Human Immunodeficiency Virus Integrase Strand Transfer Inhibitor28.4%Tivicay54%Juluca46%Part D<11 patientsHuman Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor14.2%Descovy100%Part D<11 patients+ 2 more classes in this area
Nervous system
24.4%SSRI10.2%Trazodone Hcl100%Part D<11 patientsOther antiepileptics8.1%Topiramate100%Part D<11 patients+ 1 more class in this area
Cardiovascular
15.7%Statin15.7%Atorvastatin Calcium52%Rosuvastatin Calcium48%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
6 NIH research awards on record, funded 2016–2026 per NIH RePORTER. The latest:
- CRISPR-TB for pediatric TB diagnosis and treatment response
University of Washington
FY2026$712,895R01AI179714 - CRISPR-TB for pediatric TB diagnosis and treatment response
University of Washington
FY2025$704,077R01AI179714 - M. tuberculosis exosome detection for pediatric TB diagnosis
University of Washington
FY2025$603,109R01AI162152
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Rapid tuberculosis diagnosis from respiratory or blood samples by a low cost, portable lab-in-tube assay
Science Translational Medicine
2025 - The inclusion of children and adolescents in tuberculosis diagnostic development and evaluation–a consensus statement
The Lancet Infectious Diseases
2024 - Hybrid Immunity to SARS-CoV-2 During Pregnancy Provides More Durable Infant Antibody Responses Compared to Natural Infection Alone
The Journal of Infectious Diseases
2023
Similar KOLs
Other experts from the same institution or the same specialty.
Neal Futran, MD, DMD
University of Washington
Elizabeth Swisher
University of Washington
David Tirschwell
University of Washington
Elaine Peskind, MD
University of Washington
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”